Is West Pharmaceutical Services Inc (WST) Overvalued After 3.2% Rally? GF Value Says Overvalued

gurufocus.com · 2026-10-05

On October 05, 2026, West Pharmaceutical Services Inc (WST) shares rose 3.2% to $376.76, continuing its strong price performance with a 52-week range of $223.83

TickrTrends take: West Pharmaceutical Services operates in the Healthcare sector where valuation metrics can shift quickly based on operational performance and market conditions. TickrTrends currently assesses WST as fairly valued, which contrasts with the overvaluation assessment cited in recent analysis following the stock's recent rally. Investors focused on valuation should monitor whether WST's fundamentals can support its current price levels or whether the gap between different valuation methodologies will narrow.

Read the full story at gurufocus.com →